Two Sigma Advisers’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Sell |
940,600
-274,400
| -23% | -$604K | ﹤0.01% | 1100 |
|
|
2025
Q1 | $1.41M | Sell |
1,215,000
-442,000
| -27% | -$513K | ﹤0.01% | 1297 |
|
|
2024
Q4 | $2.1M | Buy |
1,657,000
+528,000
| +47% | +$671K | ﹤0.01% | 1100 |
|
|
2024
Q3 | $3.85M | Buy |
1,129,000
+272,500
| +32% | +$929K | 0.01% | 797 |
|
|
2024
Q2 | $4M | Sell |
856,500
-377,800
| -31% | -$1.76M | 0.01% | 866 |
|
|
2024
Q1 | $9.16M | Buy |
1,234,300
+92,800
| +8% | +$689K | 0.02% | 563 |
|
|
2023
Q4 | $11.6M | Buy |
1,141,500
+66,500
| +6% | +$674K | 0.03% | 472 |
|
|
2023
Q3 | $8.39M | Buy |
1,075,000
+284,600
| +36% | +$2.22M | 0.02% | 524 |
|
|
2023
Q2 | $6.5M | Sell |
790,400
-110,600
| -12% | -$910K | 0.02% | 656 |
|
|
2023
Q1 | $6.53M | Sell |
901,000
-194,500
| -18% | -$1.41M | 0.02% | 701 |
|
|
2022
Q4 | $9.72M | Buy |
1,095,500
+19,000
| +2% | +$169K | 0.03% | 522 |
|
|
2022
Q3 | $13.2M | Buy |
1,076,500
+100,000
| +10% | +$1.22M | 0.04% | 426 |
|
|
2022
Q2 | $11.6M | Buy |
976,500
+93,000
| +11% | +$1.1M | 0.03% | 470 |
|
|
2022
Q1 | $16.8M | Buy |
883,500
+124,100
| +16% | +$2.36M | 0.04% | 362 |
|
|
2021
Q4 | $20.2M | Buy |
759,400
+346,500
| +84% | +$9.2M | 0.05% | 306 |
|
|
2021
Q3 | $17M | Sell |
412,900
-253,900
| -38% | -$10.4M | 0.04% | 356 |
|
|
2021
Q2 | $37.8M | Buy |
666,800
+71,300
| +12% | +$4.04M | 0.1% | 213 |
|
|
2021
Q1 | $25M | Buy |
595,500
+186,900
| +46% | +$7.85M | 0.07% | 304 |
|
|
2020
Q4 | $28.6M | Sell |
408,600
-224,600
| -35% | -$15.7M | 0.08% | 262 |
|
|
2020
Q3 | $17.8M | Buy |
633,200
+27,000
| +4% | +$758K | 0.05% | 352 |
|
|
2020
Q2 | $17.9M | Sell |
606,200
-900
| -0.1% | -$26.6K | 0.05% | 354 |
|
|
2020
Q1 | $12M | Buy |
607,100
+189,600
| +45% | +$3.76M | 0.05% | 423 |
|
|
2019
Q4 | $12.4M | Buy |
417,500
+114,500
| +38% | +$3.39M | 0.03% | 526 |
|
|
2019
Q3 | $6.89M | Buy |
303,000
+129,200
| +74% | +$2.94M | 0.02% | 659 |
|
|
2019
Q2 | $4.3M | Buy |
173,800
+61,900
| +55% | +$1.53M | 0.01% | 891 |
|
|
2019
Q1 | $2.74M | Buy |
111,900
+5,600
| +5% | +$137K | 0.01% | 1085 |
|
|
2018
Q4 | $2.42M | Buy |
106,300
+19,100
| +22% | +$434K | 0.01% | 1092 |
|
|
2018
Q3 | $2.78M | Buy |
87,200
+1,600
| +2% | +$50.9K | 0.01% | 1076 |
|
|
2018
Q2 | $3.07M | Buy |
85,600
+35,100
| +70% | +$1.26M | 0.01% | 1090 |
|
|
2018
Q1 | $1.67M | Buy |
50,500
+24,000
| +91% | +$796K | ﹤0.01% | 1329 |
|
|
2017
Q4 | $814K | Buy |
+26,500
| New | +$814K | ﹤0.01% | 1594 |
|